Munguia-Ramos D, Xancal-Salvador L, Esteban-Kenel V, Ortiz-Conchi N, Jaimes-Aquino R, Mendoza-Rojas M
Antibiotics (Basel). 2024; 13(11).
PMID: 39596798
PMC: 11591157.
DOI: 10.3390/antibiotics13111105.
Simner P, Pitout J, Dingle T
Clin Microbiol Rev. 2024; 37(4):e0005422.
PMID: 39545731
PMC: 11629623.
DOI: 10.1128/cmr.00054-22.
Alraddadi B, Heaphy E, Alzahrani M, Alqadi M, Qashqari M, Alhuthali M
Infect Drug Resist. 2024; 17:4655-4664.
PMID: 39473910
PMC: 11520729.
DOI: 10.2147/IDR.S479487.
Xiao Y, Duan J, Tan C, Zou J, Chen S, Liu T
Sci Rep. 2024; 14(1):26017.
PMID: 39472675
PMC: 11522463.
DOI: 10.1038/s41598-024-76261-9.
Santajit S, Tunyong W, Kong-Ngoen T, Arsheewa W, Hinthong W, Pumirat P
Microbiol Spectr. 2024; :e0019824.
PMID: 39417625
PMC: 11619526.
DOI: 10.1128/spectrum.00198-24.
Preventing and Controlling Healthcare-Associated Infections: The First Principle of Every Antimicrobial Stewardship Program in Hospital Settings.
Sartelli M, Marini C, McNelis J, Coccolini F, Rizzo C, Labricciosa F
Antibiotics (Basel). 2024; 13(9).
PMID: 39335069
PMC: 11428707.
DOI: 10.3390/antibiotics13090896.
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.
Trad N, Mohamed G, Bizid S, Abdallah H, Bouali R, Abdelli M
Future Sci OA. 2024; 10(1):FSO945.
PMID: 38813115
PMC: 11131343.
DOI: 10.2144/fsoa-2023-0160.
Carbapenemase producing at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics.
Carroll A, Carman R, Bannerman T, Pancholi P
Infect Prev Pract. 2024; 6(2):100366.
PMID: 38765915
PMC: 11101937.
DOI: 10.1016/j.infpip.2024.100366.
A practical approach to screening for carbapenemase-producing Enterobacterales- views of a group of multidisciplinary experts from English hospitals.
Jenkins D, Auckland C, Chadwick C, Dodgson A, Enoch D, Goldenberg S
BMC Infect Dis. 2024; 24(1):444.
PMID: 38671365
PMC: 11046869.
DOI: 10.1186/s12879-024-09307-y.
ANCA: artificial nucleic acid circuit with argonaute protein for one-step isothermal detection of antibiotic-resistant bacteria.
Jang H, Song J, Kim S, Byun J, Lee K, Park K
Nat Commun. 2023; 14(1):8033.
PMID: 38052830
PMC: 10697997.
DOI: 10.1038/s41467-023-43899-4.
Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital.
De Vita E, De Angelis L, Arzilli G, Baglivo F, Barnini S, Vecchione A
Pathogens. 2023; 12(9).
PMID: 37764948
PMC: 10535761.
DOI: 10.3390/pathogens12091140.
Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing and Differentiation of Carbapenem-Resistant .
Takei K, Kanamori H, Nakayama A, Chiba M, Takei Y, Seike I
Antibiotics (Basel). 2023; 12(7).
PMID: 37508242
PMC: 10376669.
DOI: 10.3390/antibiotics12071146.
Individualized active surveillance for carbapenem-resistant microorganisms using Xpert Carba-R in intensive care units.
Zhou S, Mi S, Rao X, Zhang Q, Wei S, Xiao M
Sci Rep. 2023; 13(1):9527.
PMID: 37308521
PMC: 10261131.
DOI: 10.1038/s41598-023-36321-y.
Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Colonization and Subsequent Infection.
Yuan W, Xu J, Guo L, Chen Y, Gu J, Zhang H
Microbiol Spectr. 2022; 10(6):e0190621.
PMID: 36445086
PMC: 9769896.
DOI: 10.1128/spectrum.01906-21.
An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant .
Rabaan A, Eljaaly K, Alhumaid S, Albayat H, Al-Adsani W, Sabour A
Medicina (Kaunas). 2022; 58(11).
PMID: 36422214
PMC: 9696003.
DOI: 10.3390/medicina58111675.
Assessing Colistin Resistance by Phenotypic and Molecular Methods in Carbapenem-resistant Enterobacterales in a Tertiary Care Hospital in Pakistan.
Furqan W, Ali S, Usman J, Hanif F, Naeem A, Nasrullah A
Infect Drug Resist. 2022; 15:5899-5904.
PMID: 36237291
PMC: 9553232.
DOI: 10.2147/IDR.S376490.
Occurrence of Healthcare-Associated Infections (HAIs) by and spp. Producing Extended-Spectrum β-lactamases (ESBL) and/or Carbapenemases in Portuguese Long-Term Care Facilities.
Machado E, Costa P, Carvalho A, The Sarel Investigators
Pathogens. 2022; 11(9).
PMID: 36145451
PMC: 9504074.
DOI: 10.3390/pathogens11091019.
NDM-beta-lactamase-1: Where do we stand?.
Bose P, Rangnekar A, Desikan P
Indian J Med Res. 2022; 155(2):243-252.
PMID: 35946201
PMC: 9629525.
DOI: 10.4103/ijmr.IJMR_685_19.
The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
Lu L, Xu C, Tang Y, Wang L, Cheng Q, Chen X
Infect Drug Resist. 2022; 15:2901-2914.
PMID: 35693849
PMC: 9176635.
DOI: 10.2147/IDR.S359833.
Effectiveness of Antiepidemic Measures Aimed to Reduce Carbapenemase-Producing Enterobacteriaceae in the Hospital Environment.
Pawlak M, Lewtak K, Nitsch-Osuch A
Can J Infect Dis Med Microbiol. 2022; 2022:9299258.
PMID: 35528804
PMC: 9072043.
DOI: 10.1155/2022/9299258.